Deal Announcements

Novasys Medical Closes $50 Million Series D

Monday, May 19, 2008 5:53:00 AM PDT | VentureDeal Staff

Newark, CA -- Medical device company Novasys Medical, Inc. announced that it has secured $49.5 million in new venture capital funding from a syndicate of firms.

Novasys is developing novel therapies for the treatment of female pelvic disorders.  The company's initial focus is on treatments for female stress urinary incontinence.

Investors in the round included Versant Ventures, Three Arch Partners, Skyline Ventures, Delphi Ventures, Alloy Ventures, Affinity Capital, Onset Ventures, J.P. Morgan Partners and Invesco Private Capital.

The company said it would use the funds to bring its Renessa nonsurgical treatment to women suffering from stress urinary incontinence.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1